SCHEMBL6162828

SCHEMBL6162828

CCCc1nn(CCO)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALPL P05186 2/20 0.63
ALDH1A1 P00352 4/20 0.55
NPSR1 Q6W5P4 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.41
HTT P42858 3/20 0.40
HDAC1 Q13547 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
OPRM1 P35372 2/20 0.38
BUB1 O43683 1/20 0.37
HSD17B10 Q99714 2/20 0.36
HDAC4 P56524 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166123 0.83 ALPL (0.43) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6162505 0.82 ALPL (0.67) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6165525 0.81 HTT (0.61) KMT2AHTTHDAC1HDAC6OPRM1
SCHEMBL6164099 0.78 HTT (0.66) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6165665 0.77 ALPL (0.39) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6164100 0.77 HDAC1 (0.45) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6164718 0.77 HTT (0.41) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6164113 0.77 OPRM1 (0.49) ALPLALDH1A1NPSR1KMT2ALMNA
SCHEMBL6163497 0.76 HTT (0.40) ALPLALDH1A1NPSR1KMT2AHTT
SCHEMBL6164449 0.73 HTT (0.38) ALPLALDH1A1NPSR1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed